Simple Summary Prostate cancer (PCa) is a widespread malignancy, representing the
second leading cause of cancer-related death in men. In the last years, liquid biopsy has …

Abstract Background In the United States, Black men are at highest risk for being diagnosed
with and dying from prostate cancer. Given this disparity, we examined relevant data to …

The reduction in androgen synthesis and the blockade of the androgen receptor (AR)
function by chemical castration and AR signaling inhibitors represent the main treatment …

The vast majority of new prostate cancer diagnoses are low-grade tumors that are monitored
by active surveillance rather than undergoing immediate treatment. However, a subset of …

Background Prostate cancer has been well known to have a high prevalence among middle-
aged and older men, with high incidence of metastases to the bone—the main metastatic …

Objetivo: Avaliar a relação entre a hiperplasia prostática benigna (HPB) e o
adenocarcinoma prostático (AP) por meio da quantificação de neutrófilos, eosinófilos e …

The development of new screening methods and diagnostic tests for traits, common
diseases, and cancer is linked to the advent of precision genomic medicine, in which health …

Objective: To evaluate the relationship between benign prostatic hyperplasia (BPH) and
prostatic adenocarcinoma (AP) through the quantification of neutrophils, eosinophils and …

Prostate cancer (PC) is a major health problem among men in the western world. The
prognosis of PC varies, with high mortality rates for high-risk disease in contrast to a mild …

This chapter provides answers to practice‐based questions with case studies covering the
new principles of diagnosis, classification, staging, treatment, and outcomes in the rapidly …